232 related articles for article (PubMed ID: 9047305)
1. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica.
Lurtz MM; Hareland ML; Pedersen SE
Biochemistry; 1997 Feb; 36(8):2068-75. PubMed ID: 9047305
[TBL] [Abstract][Full Text] [Related]
2. 5-Doxylstearate-induced displacement of phencyclidine from its low-affinity binding sites on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1999 Nov; 371(1):89-97. PubMed ID: 10525293
[TBL] [Abstract][Full Text] [Related]
3. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor.
Arias HR
Arch Biochem Biophys; 1996 Sep; 333(1):1-11. PubMed ID: 8806747
[TBL] [Abstract][Full Text] [Related]
4. Quinacrine noncompetitive inhibitor binding site localized on the Torpedo acetylcholine receptor in the open state.
Johnson DA; Ayres S
Biochemistry; 1996 May; 35(20):6330-6. PubMed ID: 8639577
[TBL] [Abstract][Full Text] [Related]
5. Site-selective photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor by azide derivatives of ethidium bromide.
Pedersen SE
Mol Pharmacol; 1995 Jan; 47(1):1-9. PubMed ID: 7838117
[TBL] [Abstract][Full Text] [Related]
6. Noncompetitive antagonist binding sites in the torpedo nicotinic acetylcholine receptor ion channel. Structure-activity relationship studies using adamantane derivatives.
Arias HR; Trudell JR; Bayer EZ; Hester B; McCardy EA; Blanton MP
Biochemistry; 2003 Jun; 42(24):7358-70. PubMed ID: 12809491
[TBL] [Abstract][Full Text] [Related]
7. Characterization of interaction of 3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester with Torpedo californica nicotinic acetylcholine receptor and 5-hydroxytryptamine3 receptor.
Sun H; McCardy EA; Machu TK; Blanton MP
J Pharmacol Exp Ther; 1999 Jul; 290(1):129-35. PubMed ID: 10381768
[TBL] [Abstract][Full Text] [Related]
8. Modulation of phencyclidine-sensitive ethidium binding to the Torpedo acetylcholine receptor: interaction of noncompetitive inhibitors with carbamylcholine and cobra alpha-toxin.
Valenzuela CF; Kerr JA; Duvvuri P; Johnson DA
Mol Pharmacol; 1992 Feb; 41(2):331-6. PubMed ID: 1538711
[TBL] [Abstract][Full Text] [Related]
9. Site specificity of agonist-induced opening and desensitization of the Torpedo californica nicotinic acetylcholine receptor.
Andreeva IE; Nirthanan S; Cohen JB; Pedersen SE
Biochemistry; 2006 Jan; 45(1):195-204. PubMed ID: 16388595
[TBL] [Abstract][Full Text] [Related]
10. The muscarinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor.
Amitai G; Herz JM; Bruckstein R; Luz-Chapman S
Mol Pharmacol; 1987 Nov; 32(5):678-85. PubMed ID: 3683366
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanisms and binding site location for the noncompetitive antagonist crystal violet on nicotinic acetylcholine receptors.
Arias HR; Bhumireddy P; Spitzmaul G; Trudell JR; Bouzat C
Biochemistry; 2006 Feb; 45(7):2014-26. PubMed ID: 16475790
[TBL] [Abstract][Full Text] [Related]
12. Aminotriarylmethane dyes are high-affinity noncompetitive antagonists of the nicotinic acetylcholine receptor.
Lurtz MM; Pedersen SE
Mol Pharmacol; 1999 Jan; 55(1):159-67. PubMed ID: 9882710
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
Min CK; Owens J; Weiland GA
Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439
[TBL] [Abstract][Full Text] [Related]
14. Determinants involved in the affinity of alpha-conotoxins GI and SI for the muscle subtype of nicotinic acetylcholine receptors.
Groebe DR; Gray WR; Abramson SN
Biochemistry; 1997 May; 36(21):6469-74. PubMed ID: 9174364
[TBL] [Abstract][Full Text] [Related]
15. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor.
Arias HR
Biochim Biophys Acta; 1998 Aug; 1376(2):173-220. PubMed ID: 9748559
[TBL] [Abstract][Full Text] [Related]
16. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism.
Arias HR
Mol Membr Biol; 1995; 12(4):339-47. PubMed ID: 8747279
[TBL] [Abstract][Full Text] [Related]
17. Differential agonist-induced displacement of quinacrine and ethidium from their respective histrionicotoxin-sensitive binding sites on the Torpedo acetylcholine receptor.
Arias HR; Johnson DA
Biochemistry; 1995 Feb; 34(5):1589-95. PubMed ID: 7849018
[TBL] [Abstract][Full Text] [Related]
18. Structure of the agonist-binding sites of the Torpedo nicotinic acetylcholine receptor: affinity-labeling and mutational analyses identify gamma Tyr-111/delta Arg-113 as antagonist affinity determinants.
Chiara DC; Xie Y; Cohen JB
Biochemistry; 1999 May; 38(20):6689-98. PubMed ID: 10350488
[TBL] [Abstract][Full Text] [Related]
19. The steroid promegestone is a noncompetitive antagonist of the Torpedo nicotinic acetylcholine receptor that interacts with the lipid-protein interface.
Blanton MP; Xie Y; Dangott LJ; Cohen JB
Mol Pharmacol; 1999 Feb; 55(2):269-78. PubMed ID: 9927618
[TBL] [Abstract][Full Text] [Related]
20. Interaction of a benzomorphan opiate with acetylcholinesterase and the nicotinic acetylcholine receptor.
Coleman BA; Michel L; Oswald R
Mol Pharmacol; 1987 Oct; 32(4):456-62. PubMed ID: 3670280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
